Neurosoft Biologics
3 known investors
Find your way into Neurosoft Biologics
562 people in our graph share verified history with the Neurosoft Biologics team — schools, employers, funds. One of them is your warm intro.
Ken Chenaultunlockedknows Florian Fallegger · together at IBM Switzerland (overlapped)
×2knows the team · via Harvard University
knows the team · via Northwestern University
×6knows the team · via Massachusetts Eye and Ear Infirmary - Harvard Medical School
knows the team · via PARC Inc, a Xerox Company
knows the team · via EPFL
Neurosoft Bio develops soft, elastic brain-computer interfaces that reduce mechanical mismatch with neural tissue for safer, longer-term implantation, and applies AI to analyze brain recordings for biomarker detection, neuromodulation, and decoding of motor and speech intentions. Its medical devices target patients with neurological disorders.
Founders & leadership
NV

Nicolas VachicourasinCEO & Co-FounderHe has expertise in micro-nanotechnologies applied to neural interfaces and medical device development.
LS

Ludovic SerexinCTO & Co-FounderLudovic Serex holds a PhD and co-founded Neurosoft Biologics, where he leads engineering, device design, and manufacturing operations as CTO. His background spans robotics, micro-fabrication, and bio-printing technologies.
FF

Florian FalleggerinCo-Founder & CSO AdvisorFlorian Fallegger is a postdoctoral researcher in vision restoration and novel brain stimulation approaches. He is co-founder and CSO advisor at Neurosoft Biologics, which develops soft implantable brain-computer interfaces and AI-powered brain recording analysis for neurological applications.
SL

Stéphanie LacourinCo-Founder, Full Professor & VP for Support to Strategic Initiatives (EPFL)
Investors · 3
Competitors · 6
by search overlapEMOTIV5 shared keywordsEmotiv develops wearable EEG systems and software platforms that capture and analyze brain signals to support neuroscience research, brain-computer interfaces, and cognitive AI applications. The platform serves researchers, developers, and organizations seeking to understand brain function and enable human-computer interaction.
OpenBCI4 shared keywords
NeuroSky4 shared keywordsNeuroSky provides biofeedback and biometric assessment solutions that help companies optimize hiring decisions, identify employee training needs, and improve workforce productivity through data-driven insights on cognitive performance and employee capabilities.
Neurable3 shared keywordsNeurable develops brain-computer interface (BCI) technology via smart headphones designed to enhance employee focus, productivity, and well-being in corporate settings. The solution targets organizations seeking to reduce staff burnout and optimize team performance in remote and high-pressure work environments.
Cognixion3 shared keywordsCognixion develops non-invasive brain-computer interfaces and adaptive assistive technology that provide communication and control for people with complex disabilities. Its multimodal systems combine intent, context, and accessible spatial computing across interfaces such as the Apple Vision Pro.
Neuralink3 shared keywordsNeurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
Companies competing with Neurosoft Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Neurosoft Biologics do?
- Neurosoft Bio develops soft, elastic brain-computer interfaces that reduce mechanical mismatch with neural tissue for safer, longer-term implantation, and applies AI to analyze brain recordings for biomarker detection, neuromodulation, and decoding of motor and speech intentions. Its medical devices target patients with neurological disorders.
- Who founded Neurosoft Biologics?
- Neurosoft Biologics was founded by Nicolas Vachicouras, Ludovic Serex, Florian Fallegger, Stéphanie Lacour.
- Who are Neurosoft Biologics's investors?
- Neurosoft Biologics's investors include Connecticut Innovations, Kickfund, SmartGateVC.







